Pricing Log in Create free account
Reset Show values
Sector
Industry
Country
Exclude ADRs
Ticker
Market Cap

Your own ranges are part of Powerpack. Powerpack

Stock Price

Your own ranges are part of Powerpack. Powerpack

Beta

Your own ranges are part of Powerpack. Powerpack

Employees

Your own ranges are part of Powerpack. Powerpack

Years since IPO

Your own ranges are part of Powerpack. Powerpack

S&P 500 Member
Nasdaq 100 Member
Dow Jones Member
Price Change (1M)

Your own ranges are part of Powerpack. Powerpack

Price Change (1Y)

Your own ranges are part of Powerpack. Powerpack

Price Change (YTD)

Your own ranges are part of Powerpack. Powerpack

52-week high (new)
Insider Ownership

Your own ranges are part of Powerpack. Powerpack

Recommendation Rating

Your own ranges are part of Powerpack. Powerpack

Target vs Price (Average)

Your own ranges are part of Powerpack. Powerpack

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 21 matches.
1 filter active
median
thirds
Free account

See all 21 matches

This screen shows only its 10 largest companies. A free account shows every match of every screen you run, and keeps one screen for you. No card.

Create free account
Powerpack

Export it, tune it, and hear when it changes

Download any screen to Excel, set your own range on any filter, and get an email the day a company enters or leaves a screen you saved.

Start 7-day free trial

Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time.

Also in Powerpack: every quarter, analyst estimates, API & MCP access. Compare plans

Table Snapshots
No.
1 LLY Eli Lilly and Company Revenue Growth for LLY EPS Growth (diluted) for LLY Net Income Growth for LLY Operating Income Growth for LLY Free Cash Flow Growth for LLY 3Y Reveue Growth (CAGR) for LLY 5Y Revenue Growth (CAGR) for LLY 10Y Revenue Growth (CAGR) for LLY 5Y Net Income Growth (CAGR) for LLY 41.53% 33.21%
2 JNJ Johnson & Johnson Revenue Growth for JNJ EPS Growth (diluted) for JNJ Net Income Growth for JNJ Operating Income Growth for JNJ Free Cash Flow Growth for JNJ 3Y Reveue Growth (CAGR) for JNJ 5Y Revenue Growth (CAGR) for JNJ 10Y Revenue Growth (CAGR) for JNJ 5Y Net Income Growth (CAGR) for JNJ 4.27% 8.95%
3 ABBV AbbVie Inc. Revenue Growth for ABBV EPS Growth (diluted) for ABBV Net Income Growth for ABBV Operating Income Growth for ABBV Free Cash Flow Growth for ABBV 3Y Reveue Growth (CAGR) for ABBV 5Y Revenue Growth (CAGR) for ABBV 10Y Revenue Growth (CAGR) for ABBV 5Y Net Income Growth (CAGR) for ABBV 16.77% 21.70%
4 MRK Merck & Co., Inc. Revenue Growth for MRK EPS Growth (diluted) for MRK Net Income Growth for MRK Operating Income Growth for MRK Free Cash Flow Growth for MRK 3Y Reveue Growth (CAGR) for MRK 5Y Revenue Growth (CAGR) for MRK 10Y Revenue Growth (CAGR) for MRK 5Y Net Income Growth (CAGR) for MRK 221.14% 3.37%
5 NVS Novartis AG Revenue Growth for NVS EPS Growth (diluted) for NVS Net Income Growth for NVS Operating Income Growth for NVS Free Cash Flow Growth for NVS 3Y Reveue Growth (CAGR) for NVS 5Y Revenue Growth (CAGR) for NVS 10Y Revenue Growth (CAGR) for NVS 5Y Net Income Growth (CAGR) for NVS 11.18% 6.41%
6 AZN AstraZeneca PLC Revenue Growth for AZN EPS Growth (diluted) for AZN Net Income Growth for AZN Operating Income Growth for AZN Free Cash Flow Growth for AZN 3Y Reveue Growth (CAGR) for AZN 5Y Revenue Growth (CAGR) for AZN 10Y Revenue Growth (CAGR) for AZN 5Y Net Income Growth (CAGR) for AZN 10.56% 11.24%
7 AMGN Amgen Inc. Revenue Growth for AMGN EPS Growth (diluted) for AMGN Net Income Growth for AMGN Operating Income Growth for AMGN Free Cash Flow Growth for AMGN 3Y Reveue Growth (CAGR) for AMGN 5Y Revenue Growth (CAGR) for AMGN 10Y Revenue Growth (CAGR) for AMGN 5Y Net Income Growth (CAGR) for AMGN 6.30% 6.96%
8 GILD Gilead Sciences, Inc. Revenue Growth for GILD EPS Growth (diluted) for GILD Net Income Growth for GILD Operating Income Growth for GILD Free Cash Flow Growth for GILD 3Y Reveue Growth (CAGR) for GILD 5Y Revenue Growth (CAGR) for GILD 10Y Revenue Growth (CAGR) for GILD 5Y Net Income Growth (CAGR) for GILD 1,290.88% 9.77%
9 PFE Pfizer Inc. Revenue Growth for PFE EPS Growth (diluted) for PFE Net Income Growth for PFE Operating Income Growth for PFE Free Cash Flow Growth for PFE 3Y Reveue Growth (CAGR) for PFE 5Y Revenue Growth (CAGR) for PFE 10Y Revenue Growth (CAGR) for PFE 5Y Net Income Growth (CAGR) for PFE (3.03%) (8.39%)
10 NVO Novo Nordisk A/S Revenue Growth for NVO EPS Growth (diluted) for NVO Net Income Growth for NVO Operating Income Growth for NVO Free Cash Flow Growth for NVO 3Y Reveue Growth (CAGR) for NVO 5Y Revenue Growth (CAGR) for NVO 10Y Revenue Growth (CAGR) for NVO 5Y Net Income Growth (CAGR) for NVO (1.08%) 0.20%